Klick Health lends expertise to COVID-19 digital health tools
The Number One agency on our Agency 100 list is collaborating with outside organizations to develop digital tools to help combat COVID-19.
Research & Development
Cost of innovation making fight against superbugs near impossible
Sander Flaum discusses the DISARM act and how we can fight back against antibiotic resistance.
Huge market, huge opportunity: China’s journey to health transformation
As the country contends with the spread of the coronavirus, China’s next decade will see the evolution of health policy and regulation.
Pipeline Report 2020: Drugs rising from R&D purgatory, new vaccines set to surge in coming year
Several candidates relegated to the R&D graveyard re-emerged from their tombs this year and now headline the pharma developmental slate for 2020.
Study: Cancer, orphan drugs dominate pharma launches, R&D in 2018
IQVIA examined the research and development landscape of 2018.
WPP Health Practice teams up with London School of Hygiene & Tropical Medicine
The holding company health unit will work with the university on its initiatives around the world.
Continued research depends on fair prices for treatments
Sander Flaum explains why continued research depends on fair prices for treatments.
Three data architects share the secrets of their universe
Three of the industry’s top data architects reflect on their careers, opine on pharma’s “data revolution,” muse on the future of AI in healthcare, and unravel the secrets of their universe.
The caregiver’s journey is a highly personal one. A study examined their role in treatment decisions
Caregivers are intimately involved in patient health, and that includes deciding on treatments, a new study suggests.
Vanessa Thirion-Cullity, Novartis Oncology
Vanessa Thirion-Cullity is executive director, U.S. NET of Novartis Oncology.
